A Facile Route of Synthesis for Making Flibanserin

Author:

Yang Feipu12,Wu Chunhui3,Li Zhiqiang3,Tian Guanghui3,Wu Jianzhong3,Zhu Fuqiang3,Zhang Jian3,He Yang1,Shen Jingshan1

Affiliation:

1. CAS Key Laboratory for Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China

2. University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China

3. Topharman Shanghai Co., Ltd., 1088 Chuansha Road, Shanghai 201209, China

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Reference12 articles.

1. Flibanserin: First Global Approval

2. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women

3. Bietti, G.; Borsini, F.; Turconi, M.; Giraldo, E.; Bignotti, M.For treatment of central nervous system disorders. U.S. Patent 5,576,318, 1996.

4. Mohan Rao, D.; Krishna Reddy, P.; Venkat Reddy, B.Preparing benzoimidazol-2-one compound, useful to prepare flibanserin, comprises reacting benzoimidazol-2-one compound with 2-(2-hydroxy-ethylamino)-ethanol to give (bis-(hydroxy-ethyl)-amino)-ethyl-benzoimidazol-2-one compound. PCT. Int.WO2,010,128,516, 2010.5.

5. Synthesis of 1-alkyl and 1,3-dialkyl-2-benzimidazolones from 1-alkenyl-2-benzimidazolones using phase-transfer catalysis technique

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3